Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (VELIA)
A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel With or Without Concurrent and Continuation Maintenance Veliparib (PARP Inhibitor) in Subjects With Previously Untreated Stages III or IV High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Sponsor: AbbVie
Terminated
Business decision not related to patient safety
Other terminated trials from AbbVie
Other Ovarian Cancer trials with similar outcome
A PHASE3 clinical study on Ovarian Cancer and Ovarian Neoplasm, this trial is terminated or withdrawn. The trial is conducted by AbbVie and has accumulated 26 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
26 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Feb 2025 — Sep 2025 [monthly]
Terminated PHASE3
-
Nov 2024 — Feb 2025 [monthly]
Terminated PHASE3
-
Sep 2024 — Nov 2024 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
▶ Show 21 earlier versions
-
Nov 2023 — Jul 2024 [monthly]
Terminated PHASE3
Status: Active Not Recruiting → Terminated
-
Aug 2023 — Nov 2023 [monthly]
Active Not Recruiting PHASE3
-
Jul 2022 — Aug 2023 [monthly]
Active Not Recruiting PHASE3
-
Sep 2021 — Jul 2022 [monthly]
Active Not Recruiting PHASE3
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE3
-
Oct 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
-
Jun 2020 — Oct 2020 [monthly]
Active Not Recruiting PHASE3
-
Apr 2020 — Jun 2020 [monthly]
Active Not Recruiting PHASE3
-
Oct 2019 — Apr 2020 [monthly]
Active Not Recruiting PHASE3
-
Jul 2019 — Oct 2019 [monthly]
Active Not Recruiting PHASE3
-
Nov 2018 — Jul 2019 [monthly]
Active Not Recruiting PHASE3
-
Aug 2018 — Nov 2018 [monthly]
Active Not Recruiting PHASE3
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting PHASE3
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
-
Feb 2018 — May 2018 [monthly]
Active Not Recruiting PHASE3
-
Oct 2017 — Feb 2018 [monthly]
Active Not Recruiting PHASE3
-
Aug 2017 — Oct 2017 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
May 2017 — Aug 2017 [monthly]
Recruiting PHASE3
-
Mar 2017 — May 2017 [monthly]
Recruiting PHASE3
-
Feb 2017 — Mar 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Jul 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AbbVie
- Australia New Zealand Gynaecological Oncology Group
For direct contact, visit the study record on ClinicalTrials.gov .